Cargando…

Therapeutic Usefulness of a Novel Calcium Channel Blocker Azelnidipine in the Treatment of Hypertension: A Narrative Review

The prevalence of hypertension and comorbidities such as metabolic syndrome, diabetes mellitus, and chronic kidney disease in India is alarmingly high. Amlodipine, an older-generation calcium channel blocker (CCB), is currently the gold standard for hypertension management in India. However, it has...

Descripción completa

Detalles Bibliográficos
Autor principal:	Ram, C. Venkata S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652186/ https://www.ncbi.nlm.nih.gov/pubmed/35969319 http://dx.doi.org/10.1007/s40119-022-00276-4

Ejemplares similares

Clinical use of azelnidipine in the treatment of hypertension in Chinese patients
por: Chen, Bi-Lian, et al.
Publicado: (2015)

Inhibitory Effects of Azelnidipine Tablets on Morning Hypertension
por: Kario, Kazuomi, et al.
Publicado: (2013)

Azelnidipine Inhibits the Differentiation and Activation of THP-1 Macrophages through the L-Type Calcium Channel
por: Komoda, Hiroshi, et al.
Publicado: (2018)

A New Baroreceptor Sensitivity-Restoring Ca-Channel Blocker Diminishes Age-Related Morning Blood Pressure Increase in Hypertensive Patients: Open-Label Monitoring of Azelnidipine Treatment for Hypertension in the Early Morning (At-HOME) Study
por: Kario, Kazuomi, et al.
Publicado: (2010)

Effect of Calcium Channel Blockers versus Diuretics for Hypertension
por: Chunxue, Yi, et al.
Publicado: (2022)

Effects of calcium channel blockers on glucose tolerance, inflammatory state, and circulating progenitor cells in non-diabetic patients with essential hypertension: a comparative study between Azelnidipine and amlodipine on glucose tolerance and endothelial function - a crossover trial (AGENT)
por: Fukao, Kosuke, et al.
Publicado: (2011)

Treatment for calcium channel blocker poisoning: A systematic review
por: St-Onge, M., et al.
Publicado: (2014)

Treatment of calcium channel blocker overdose with levosimendan
por: Sencan, A, et al.
Publicado: (2011)

Treatment Modalities in Calcium Channel Blocker Overdose: A Systematic Review
por: Baid, Himanshi, et al.
Publicado: (2023)

An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015)

Pulmonary arterial hypertension sensitive to calcium channel blocker, but not advanced pulmonary hypertension treatment: a case report
por: Hirakawa, Kyoko, et al.
Publicado: (2022)

Current concepts in combination therapy for the treatment of hypertension: combined calcium channel blockers and RAAS inhibitors
por: Rubio-Guerra, Alberto F, et al.
Publicado: (2009)

The Long-Term Response to Treatment with Calcium Channel Blockers in Patients with Idiopathic Pulmonary Arterial Hypertension
por: Kiani, Azam, et al.
Publicado: (2023)

Calcium channel blockers improve prognosis of patients with coronavirus disease 2019 and hypertension
por: Peng, Chi, et al.
Publicado: (2021)

Pleiotropic Effects of Calcium Channel Blockers
por: Preston Mason, R.
Publicado: (2012)

Calcium channel blockers and Alzheimer's disease★
por: Tan, Yi, et al.
Publicado: (2012)

Discovery and Development of Calcium Channel Blockers
por: Godfraind, Théophile
Publicado: (2017)

Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or β-blockers for treating hypertension
por: Bisognano, John D, et al.
Publicado: (2007)

Sex Differences in the Anti-Hypertensive Effect of Calcium-Channel Blockers: A Systematic Review and Meta-Analysis
por: van Luik, Eveline M., et al.
Publicado: (2023)

Azelnidipine protects myocardium in hyperglycemia-induced cardiac damage
por: Kain, Vasundhara, et al.
Publicado: (2010)

Calcium-Channel Blockers: An Alternative Therapy to Beta-Blockers for Myocardial Infarction?
por: Hao, Kiyotaka, et al.
Publicado: (2023)

Adenosine modulators and calcium channel blockers as add-on treatment for schizophrenia
por: Lintunen, Jonne, et al.
Publicado: (2021)

Calcium Channel Blockers as Tocolytics: Principles of Their Actions, Adverse Effects and Therapeutic Combinations
por: Gáspár, Róbert, et al.
Publicado: (2013)

Comparative Effect of Calcium Channel Blockers on Glomerular Function in Hypertensive Patients with Diabetes Mellitus
por: Nishida, Yayoi, et al.
Publicado: (2017)

Blood pressure lowering effect of calcium channel blockers on perioperative hypertension: A systematic review and meta-analysis
por: Lin, Yu, et al.
Publicado: (2018)

Azelnidipine prevents cardiac dysfunction in streptozotocin-diabetic rats by reducing intracellular calcium accumulation, oxidative stress and apoptosis
por: Kain, Vasundhara, et al.
Publicado: (2011)

Comparison of Azelnidipine and Trichlormethiazide in Japanese Type 2 Diabetic Patients with Hypertension: The COAT Randomized Controlled Trial
por: Takihata, Masahiro, et al.
Publicado: (2015)

Synthesis of Pseudellone Analogs and Characterization as Novel T-type Calcium Channel Blockers
por: Wang, Dan, et al.
Publicado: (2018)

Effects of calcium channel blockers on potassium homeostasis.
por: Freed, M. I., et al.
Publicado: (1991)

Neuroprotective effects of blockers for T-type calcium channels
por: Wildburger, Norelle C, et al.
Publicado: (2009)

Calcium channel blocker overdose: Experience with amlodipine
por: Ghosh, Supradip, et al.
Publicado: (2008)

The role of calcium channel blockers in wound healing
por: Mojiri-Forushani, Hoda
Publicado: (2018)

Calcium Channel Blocker-induced Gingival Overgrowth
por: Matsuura, Hiroki, et al.
Publicado: (2018)

Repurposing calcium channel blockers as antiviral drugs
por: Jayaseelan, Vijayashree Priyadharsini, et al.
Publicado: (2020)

Are calcium channel blockers related to lung cancer?
por: Rattanathanoo, Ratchanon, et al.
Publicado: (2023)

Calcium Channel Blocker Toxicity: A Practical Approach
por: Alshaya, Omar A, et al.
Publicado: (2022)

Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis
por: Ma, Haotian, et al.
Publicado: (2021)

A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention
por: Wang, Ji-Guang
Publicado: (2009)

Beta-Blocker and Calcium Channel Blocker Toxicity With BRASH Syndrome: A Case Report
por: Martinez, Adolfo, et al.
Publicado: (2023)

A Discrepancy: Calcium Channel Blockers Are Effective for the Treatment of Hypertensive Left Ventricular Hypertrophy but Not as Effective for Prevention of Heart Failure
por: Koracevic, Goran, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s9klsvdpdb1mbc5c7muoog3kq3